News

Buckman galvanises LMCs and earns two standing ovations

12-Jun-08

In a maiden address as chairman of the GPC, Dr Laurence Buckman galvanised colleagues at the opening of the annual conference of the LMCs.

Focusing throughout on the government as the current arch enemy of general practice he protested against the ‘assault on GPs everywhere'.

Dr Buckman, reminded collegues that they had delivered on their side of the deal with government; on enhanced services, the quality framework, enhanced and additional services and inefficiency gains.

But he minced no words in identifying the government's own dishonesty and broken promises to GPs on MPIG, premises, enhanced services, equitable PMS returns and to impose the contract only in a national emergency.

Time and again he accused the government of applying force to get its own way. ‘You can be hung or shot,' was the choice the government offered the profession on extended hours, he said.

With a regretful nod to the commercialisation of healthcare, he rounded on the government for commercialising the health service by stealth, culminating in the use of statements such as ‘the NHS is a system and not a service.

‘I do not think the public voted for a commercial health service at the last election,' he challenged them.

Rounding up patients as allies, Dr Buckman launched a blistering attack on the commercialisation of the health service and called on the government to make it up to general practice and invest in GP premises.

But Dr Buckman reserved his fiercest irk for the polyclinics, now being forced on London and soon to spread to the rest of England.

He reminded GPs, if they needed the reminder, that the King's Fund recently reported that there was very little evidence for these new structures.

‘No doubt they will be ignored by government who will continue along its evidence-free path,' he said.

He was able to tell delegates that the petition to number 10 had been signed by 1,236,085 patients who wanted to help save their surgeries from polyclinics.

Delegated loved him and they loved his address. He toned down his traditional garish tie on the advice of the style guru for a TV friendly blue, but he did not tone down his speech to match.

The delegates gave him not one but two standing ovations, the second one lasting for one-and-a-half minutes. A triumph of a start for a leader who only got the job by default.

prisca.middlemiss@haymarket.com

Blog: Buckman nobbled by style police but retains the rough edges  

 

 

 

 

 

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Registrar

Golden rules for registrars

Medico-legal adviser Dr Jim Rodger offers some expert advice on how to excel as a GP registrar. Read more

Career paths - Working abroad in a rural practice

Dr Kingsley Poole describes the differences he experienced working at a remote practice in New Zeala... Read more

Professional development - Honing your presentation skills

Most people feel nervous facing an audience, but practice will make it easier, says Dr Kevin Brown. Read more

Show all articles

 

Latest Clinical Articles

Clinical Review - Malaria

Contributed by Dr Charlie Easmon specialist adviser in travel medicine and medical director at The N... Read more

Clinical Review - Renal colic

Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more

Clinical Review - Stroke

By Dr Helen Hosker, GP and clinical commissioning lead for stroke, NHS Manchester, and Dr Pippa Tyrr... Read more

Show all clinical articles

MIMS Product News

New drug - Xamiol

Leo Pharma has launched Xamiol gel, a combination of calcipotriol + betamethasone, for the treatment... Read more

New drug - Xarelto

Bayer HealthCare has launched Xarelto (rivaroxaban) for the prevention of venous thromboembolism in ... Read more

New drug - Torisel

Wyeth has launched Torisel (temsirolimus), a first-line treatment for advanced renal cell carcinoma ... Read more

Jobs

 

Job of the Week